Global Neuroendocrine Carcinoma Drugs Market Professional Survey Report 2017

December 2017 | 106 pages | ID: GC45D7E1F03EN
QYResearch

Abstracts

This report studies Neuroendocrine Carcinoma Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Xiaflex
• Novartis AG
• Roche
• Molecular Insight pharmaceuticals
• Callisto Pharmaceuticals

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Somatostatin Analogs
• Targeted Therapy
• Chemotherapy

By Application, the market can be split into

• Hospital
• Clinics
• Oncology Centres
• Ambulatory Surgery Centres

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Neuroendocrine Carcinoma Drugs Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF NEUROENDOCRINE CARCINOMA DRUGS

1.1 Definition and Specifications of Neuroendocrine Carcinoma Drugs
  1.1.1 Definition of Neuroendocrine Carcinoma Drugs
  1.1.2 Specifications of Neuroendocrine Carcinoma Drugs
1.2 Classification of Neuroendocrine Carcinoma Drugs
  1.2.1 Somatostatin Analogs
  1.2.2 Targeted Therapy
  1.2.3 Chemotherapy
1.3 Applications of Neuroendocrine Carcinoma Drugs
  1.3.1 Hospital
  1.3.2 Clinics
  1.3.3 Oncology Centres
  1.3.4 Ambulatory Surgery Centres
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF NEUROENDOCRINE CARCINOMA DRUGS

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Neuroendocrine Carcinoma Drugs
2.3 Manufacturing Process Analysis of Neuroendocrine Carcinoma Drugs
2.4 Industry Chain Structure of Neuroendocrine Carcinoma Drugs

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF NEUROENDOCRINE CARCINOMA DRUGS

3.1 Capacity and Commercial Production Date of Global Neuroendocrine Carcinoma Drugs Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Neuroendocrine Carcinoma Drugs Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Neuroendocrine Carcinoma Drugs Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Neuroendocrine Carcinoma Drugs Major Manufacturers in 2016

4 GLOBAL NEUROENDOCRINE CARCINOMA DRUGS OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Neuroendocrine Carcinoma Drugs Capacity and Growth Rate Analysis
  4.2.2 2016 Neuroendocrine Carcinoma Drugs Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Neuroendocrine Carcinoma Drugs Sales and Growth Rate Analysis
  4.3.2 2016 Neuroendocrine Carcinoma Drugs Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Neuroendocrine Carcinoma Drugs Sales Price
  4.4.2 2016 Neuroendocrine Carcinoma Drugs Sales Price Analysis (Company Segment)

5 NEUROENDOCRINE CARCINOMA DRUGS REGIONAL MARKET ANALYSIS

5.1 North America Neuroendocrine Carcinoma Drugs Market Analysis
  5.1.1 North America Neuroendocrine Carcinoma Drugs Market Overview
  5.1.2 North America 2012-2017E Neuroendocrine Carcinoma Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Neuroendocrine Carcinoma Drugs Sales Price Analysis
  5.1.4 North America 2016 Neuroendocrine Carcinoma Drugs Market Share Analysis
5.2 China Neuroendocrine Carcinoma Drugs Market Analysis
  5.2.1 China Neuroendocrine Carcinoma Drugs Market Overview
  5.2.2 China 2012-2017E Neuroendocrine Carcinoma Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Neuroendocrine Carcinoma Drugs Sales Price Analysis
  5.2.4 China 2016 Neuroendocrine Carcinoma Drugs Market Share Analysis
5.3 Europe Neuroendocrine Carcinoma Drugs Market Analysis
  5.3.1 Europe Neuroendocrine Carcinoma Drugs Market Overview
  5.3.2 Europe 2012-2017E Neuroendocrine Carcinoma Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Neuroendocrine Carcinoma Drugs Sales Price Analysis
  5.3.4 Europe 2016 Neuroendocrine Carcinoma Drugs Market Share Analysis
5.4 Southeast Asia Neuroendocrine Carcinoma Drugs Market Analysis
  5.4.1 Southeast Asia Neuroendocrine Carcinoma Drugs Market Overview
  5.4.2 Southeast Asia 2012-2017E Neuroendocrine Carcinoma Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Neuroendocrine Carcinoma Drugs Sales Price Analysis
  5.4.4 Southeast Asia 2016 Neuroendocrine Carcinoma Drugs Market Share Analysis
5.5 Japan Neuroendocrine Carcinoma Drugs Market Analysis
  5.5.1 Japan Neuroendocrine Carcinoma Drugs Market Overview
  5.5.2 Japan 2012-2017E Neuroendocrine Carcinoma Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Neuroendocrine Carcinoma Drugs Sales Price Analysis
  5.5.4 Japan 2016 Neuroendocrine Carcinoma Drugs Market Share Analysis
5.6 India Neuroendocrine Carcinoma Drugs Market Analysis
  5.6.1 India Neuroendocrine Carcinoma Drugs Market Overview
  5.6.2 India 2012-2017E Neuroendocrine Carcinoma Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Neuroendocrine Carcinoma Drugs Sales Price Analysis
  5.6.4 India 2016 Neuroendocrine Carcinoma Drugs Market Share Analysis

6 GLOBAL 2012-2017E NEUROENDOCRINE CARCINOMA DRUGS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Neuroendocrine Carcinoma Drugs Sales by Type
6.2 Different Types of Neuroendocrine Carcinoma Drugs Product Interview Price Analysis
6.3 Different Types of Neuroendocrine Carcinoma Drugs Product Driving Factors Analysis
  6.3.1 Somatostatin Analogs of Neuroendocrine Carcinoma Drugs Growth Driving Factor Analysis
  6.3.2 Targeted Therapy of Neuroendocrine Carcinoma Drugs Growth Driving Factor Analysis
  6.3.3 Chemotherapy of Neuroendocrine Carcinoma Drugs Growth Driving Factor Analysis

7 GLOBAL 2012-2017E NEUROENDOCRINE CARCINOMA DRUGS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Neuroendocrine Carcinoma Drugs Consumption by Application
7.2 Different Application of Neuroendocrine Carcinoma Drugs Product Interview Price Analysis
7.3 Different Application of Neuroendocrine Carcinoma Drugs Product Driving Factors Analysis
  7.3.1 Hospital of Neuroendocrine Carcinoma Drugs Growth Driving Factor Analysis
  7.3.2 Clinics of Neuroendocrine Carcinoma Drugs Growth Driving Factor Analysis
  7.3.3 Oncology Centres of Neuroendocrine Carcinoma Drugs Growth Driving Factor Analysis
  7.3.4 Ambulatory Surgery Centres of Neuroendocrine Carcinoma Drugs Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF NEUROENDOCRINE CARCINOMA DRUGS

8.1 Xiaflex
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Xiaflex 2016 Neuroendocrine Carcinoma Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Xiaflex 2016 Neuroendocrine Carcinoma Drugs Business Region Distribution Analysis
8.2 Novartis AG
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Novartis AG 2016 Neuroendocrine Carcinoma Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Novartis AG 2016 Neuroendocrine Carcinoma Drugs Business Region Distribution Analysis
8.3 Roche
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Roche 2016 Neuroendocrine Carcinoma Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Roche 2016 Neuroendocrine Carcinoma Drugs Business Region Distribution Analysis
8.4 Molecular Insight pharmaceuticals
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Molecular Insight pharmaceuticals 2016 Neuroendocrine Carcinoma Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Molecular Insight pharmaceuticals 2016 Neuroendocrine Carcinoma Drugs Business Region Distribution Analysis
8.5 Callisto Pharmaceuticals
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Callisto Pharmaceuticals 2016 Neuroendocrine Carcinoma Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Callisto Pharmaceuticals 2016 Neuroendocrine Carcinoma Drugs Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF NEUROENDOCRINE CARCINOMA DRUGS MARKET

9.1 Global Neuroendocrine Carcinoma Drugs Market Trend Analysis
  9.1.1 Global 2017-2022 Neuroendocrine Carcinoma Drugs Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Neuroendocrine Carcinoma Drugs Sales Price Forecast
9.2 Neuroendocrine Carcinoma Drugs Regional Market Trend
  9.2.1 North America 2017-2022 Neuroendocrine Carcinoma Drugs Consumption Forecast
  9.2.2 China 2017-2022 Neuroendocrine Carcinoma Drugs Consumption Forecast
  9.2.3 Europe 2017-2022 Neuroendocrine Carcinoma Drugs Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Neuroendocrine Carcinoma Drugs Consumption Forecast
  9.2.5 Japan 2017-2022 Neuroendocrine Carcinoma Drugs Consumption Forecast
  9.2.6 India 2017-2022 Neuroendocrine Carcinoma Drugs Consumption Forecast
9.3 Neuroendocrine Carcinoma Drugs Market Trend (Product Type)
9.4 Neuroendocrine Carcinoma Drugs Market Trend (Application)

10 NEUROENDOCRINE CARCINOMA DRUGS MARKETING TYPE ANALYSIS

10.1 Neuroendocrine Carcinoma Drugs Regional Marketing Type Analysis
10.2 Neuroendocrine Carcinoma Drugs International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Neuroendocrine Carcinoma Drugs by Region
10.4 Neuroendocrine Carcinoma Drugs Supply Chain Analysis

11 CONSUMERS ANALYSIS OF NEUROENDOCRINE CARCINOMA DRUGS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL NEUROENDOCRINE CARCINOMA DRUGS MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Neuroendocrine Carcinoma Drugs
Table Product Specifications of Neuroendocrine Carcinoma Drugs
Table Classification of Neuroendocrine Carcinoma Drugs
Figure Global Production Market Share of Neuroendocrine Carcinoma Drugs by Type in 2016
Figure Somatostatin Analogs Picture
Table Major Manufacturers of Somatostatin Analogs
Figure Targeted Therapy Picture
Table Major Manufacturers of Targeted Therapy
Figure Chemotherapy Picture
Table Major Manufacturers of Chemotherapy
Table Applications of Neuroendocrine Carcinoma Drugs
Figure Global Consumption Volume Market Share of Neuroendocrine Carcinoma Drugs by Application in 2016
Figure Hospital Examples
Table Major Consumers in Hospital
Figure Clinics Examples
Table Major Consumers in Clinics
Figure Oncology Centres Examples
Table Major Consumers in Oncology Centres
Figure Ambulatory Surgery Centres Examples
Table Major Consumers in Ambulatory Surgery Centres
Figure Market Share of Neuroendocrine Carcinoma Drugs by Regions
Figure North America Neuroendocrine Carcinoma Drugs Market Size (Million USD) (2012-2022)
Figure China Neuroendocrine Carcinoma Drugs Market Size (Million USD) (2012-2022)
Figure Europe Neuroendocrine Carcinoma Drugs Market Size (Million USD) (2012-2022)
Figure Southeast Asia Neuroendocrine Carcinoma Drugs Market Size (Million USD) (2012-2022)
Figure Japan Neuroendocrine Carcinoma Drugs Market Size (Million USD) (2012-2022)
Figure India Neuroendocrine Carcinoma Drugs Market Size (Million USD) (2012-2022)
Table Neuroendocrine Carcinoma Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Neuroendocrine Carcinoma Drugs in 2016
Figure Manufacturing Process Analysis of Neuroendocrine Carcinoma Drugs
Figure Industry Chain Structure of Neuroendocrine Carcinoma Drugs
Table Capacity and Commercial Production Date of Global Neuroendocrine Carcinoma Drugs Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Neuroendocrine Carcinoma Drugs Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Neuroendocrine Carcinoma Drugs Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Neuroendocrine Carcinoma Drugs Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Neuroendocrine Carcinoma Drugs 2012-2017
Figure Global 2012-2017E Neuroendocrine Carcinoma Drugs Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Neuroendocrine Carcinoma Drugs Market Size (Value) and Growth Rate
Table 2012-2017E Global Neuroendocrine Carcinoma Drugs Capacity and Growth Rate
Table 2016 Global Neuroendocrine Carcinoma Drugs Capacity (K MT) List (Company Segment)
Table 2012-2017E Global Neuroendocrine Carcinoma Drugs Sales (K MT) and Growth Rate
Table 2016 Global Neuroendocrine Carcinoma Drugs Sales (K MT) List (Company Segment)
Table 2012-2017E Global Neuroendocrine Carcinoma Drugs Sales Price (USD/MT)
Table 2016 Global Neuroendocrine Carcinoma Drugs Sales Price (USD/MT) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K MT) of Neuroendocrine Carcinoma Drugs 2012-2017E
Figure North America 2012-2017E Neuroendocrine Carcinoma Drugs Sales Price (USD/MT)
Figure North America 2016 Neuroendocrine Carcinoma Drugs Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K MT) of Neuroendocrine Carcinoma Drugs 2012-2017E
Figure China 2012-2017E Neuroendocrine Carcinoma Drugs Sales Price (USD/MT)
Figure China 2016 Neuroendocrine Carcinoma Drugs Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K MT) of Neuroendocrine Carcinoma Drugs 2012-2017E
Figure Europe 2012-2017E Neuroendocrine Carcinoma Drugs Sales Price (USD/MT)
Figure Europe 2016 Neuroendocrine Carcinoma Drugs Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K MT) of Neuroendocrine Carcinoma Drugs 2012-2017E
Figure Southeast Asia 2012-2017E Neuroendocrine Carcinoma Drugs Sales Price (USD/MT)
Figure Southeast Asia 2016 Neuroendocrine Carcinoma Drugs Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K MT) of Neuroendocrine Carcinoma Drugs 2012-2017E
Figure Japan 2012-2017E Neuroendocrine Carcinoma Drugs Sales Price (USD/MT)
Figure Japan 2016 Neuroendocrine Carcinoma Drugs Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K MT) of Neuroendocrine Carcinoma Drugs 2012-2017E
Figure India 2012-2017E Neuroendocrine Carcinoma Drugs Sales Price (USD/MT)
Figure India 2016 Neuroendocrine Carcinoma Drugs Sales Market Share
Table Global 2012-2017E Neuroendocrine Carcinoma Drugs Sales (K MT) by Type
Table Different Types Neuroendocrine Carcinoma Drugs Product Interview Price
Table Global 2012-2017E Neuroendocrine Carcinoma Drugs Sales (K MT) by Application
Table Different Application Neuroendocrine Carcinoma Drugs Product Interview Price
Table Xiaflex Information List
Table Product A Overview
Table Product B Overview
Table 2016 Xiaflex Neuroendocrine Carcinoma Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Xiaflex Neuroendocrine Carcinoma Drugs Business Region Distribution
Table Novartis AG Information List
Table Product A Overview
Table Product B Overview
Table 2016 Novartis AG Neuroendocrine Carcinoma Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Novartis AG Neuroendocrine Carcinoma Drugs Business Region Distribution
Table Roche Information List
Table Product A Overview
Table Product B Overview
Table 2015 Roche Neuroendocrine Carcinoma Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Roche Neuroendocrine Carcinoma Drugs Business Region Distribution
Table Molecular Insight pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2016 Molecular Insight pharmaceuticals Neuroendocrine Carcinoma Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Molecular Insight pharmaceuticals Neuroendocrine Carcinoma Drugs Business Region Distribution
Table Callisto Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2016 Callisto Pharmaceuticals Neuroendocrine Carcinoma Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Callisto Pharmaceuticals Neuroendocrine Carcinoma Drugs Business Region Distribution
Figure Global 2017-2022 Neuroendocrine Carcinoma Drugs Market Size (K MT) and Growth Rate Forecast
Figure Global 2017-2022 Neuroendocrine Carcinoma Drugs Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Neuroendocrine Carcinoma Drugs Sales Price (USD/MT) Forecast
Figure North America 2017-2022 Neuroendocrine Carcinoma Drugs Consumption Volume (K MT) and Growth Rate Forecast
Figure China 2017-2022 Neuroendocrine Carcinoma Drugs Consumption Volume (K MT) and Growth Rate Forecast
Figure Europe 2017-2022 Neuroendocrine Carcinoma Drugs Consumption Volume (K MT) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Neuroendocrine Carcinoma Drugs Consumption Volume (K MT) and Growth Rate Forecast
Figure Japan 2017-2022 Neuroendocrine Carcinoma Drugs Consumption Volume (K MT) and Growth Rate Forecast
Figure India 2017-2022 Neuroendocrine Carcinoma Drugs Consumption Volume (K MT) and Growth Rate Forecast
Table Global Sales Volume (K MT) of Neuroendocrine Carcinoma Drugs by Type 2017-2022
Table Global Consumption Volume (K MT) of Neuroendocrine Carcinoma Drugs by Application 2017-2022
Table Traders or Distributors with Contact Information of Neuroendocrine Carcinoma Drugs by Region